Malignant melanoma, a dangerous type of skin cancer, deploys an elegant molecular mechanism to evade natural immune responses and the therapies intended to boost them, according to new work led by scientists at the Herbert ...
Jul 31, 2023
0
60
Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study.
Jul 26, 2023
0
1
A new editorial paper titled "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" has been published in Oncotarget.
Jul 19, 2023
0
1
New research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may guide the discovery of future therapies for the disease. The study found that a protein known to be active in immune ...
Jul 5, 2023
0
19
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.
Jun 26, 2023
0
47
A new study conducted at Tel Aviv University and the Sheba Medical Center reveals how melanoma cancer cells affect their close environment to support their needs—by forming new lymph vessels in the dermis in order to go ...
Jun 14, 2023
0
4
A new study that sheds light on how B cells react to skin cancer cells could pave the way for innovative therapy design.
Jun 8, 2023
0
33
A team led by the National Cancer Centre Singapore (NCCS) with members from Singapore General Hospital, A*STAR's Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), National University ...
Jun 7, 2023
0
6
Skin cancer can pop up anywhere on your skin, including the soles of your feet and even under your fingernails.
Jun 5, 2023
0
2
Researchers from Harvard's Stem Cell and Regenerative Biology (HSCRB)'s Zon lab have discovered a new mechanism that influences melanoma development, a finding that could have wide implications for patients across a variety ...
Apr 27, 2023
0
175
